Elanco Animal Health to acquire Aratana TherapeuticsApril 30, 2019Elanco Animal Health has signed an agreement to acquire Aratana Therapeutics. The deal allows Elanco to integrate the Aratana portfolio of pet therapeutics into its companion animal therapeutics business. "Aratana has been one of the most innovative start-ups in animal health, bringing breakthrough solutions to the market," says Elanco president and chief executive officer, Jeff Simmons. "We look forward to putting greater energy behind these brands with our increased share of voice in the …
SPONSORED CONTENTLife-saving results for parvovirus casesResearch has shown that puppies treated with our Canine Parvovirus Monoclonal Antibody have shorter clinic stays.1 Transform parvo treatment outcomes for your patients. + Read More
FTC orders Mars to divest 12 vet clinics before VCA buySeptember 4, 2017To avoid violating antitrust laws, Mars Inc., under a mandate from the Federal Trade Commission, will divest 12 veterinary clinics across the U.S. that provide specialty and emergency services no later than 10 business days after the company's $9.1 billion acquisition of VCA Inc. According to the FTC, Mars is required to divest each of the 12 clincis to one of three divestiture buyers: National Veterinary Associates, Pathway Partners Vet …
